舍曲林治疗心境恶劣的疗效观察

目的:观察舍曲林治疗心境恶劣的疗效和安全性.方法:63例门诊心境恶劣患者,随机分为舍曲林组33例和安慰剂组30例,对照治疗8周.舍曲林剂量50-200mg/日.采用汉米尔顿抑郁量表(HAMD)和汉米尔顿焦虑量表(HAMA)评价疗效.结果:共54例患者完成了8周的临床观察,治疗后两组HAMD(24项)评分均有下降,舍曲林组评分明显低于安慰剂组,治疗后各个时间段评定(2周、4周、8周)两组的差异均具有统计学显著性(P<0.05～0.01).治疗8周后舍曲林组HAMA评分明显低于安慰剂组(6.7±4.5,11.7±8.3,P<0.01).8周的治疗中舍曲林组仅出现轻中度不良反应.结论:舍曲林治疗心境恶劣的疗效较好,具有良好的安全性和耐受性.

Effect of Sertraline in Treatment of Dysthymia

Objective: To observe the clinical effect of Sertraline in treatment of dysthymia. Methods:63 outpatients diagnosed as dysthymia according to ICD-10 were randomly assigned to study group (n=33) and placebo group. Randomized double blind control study was done for 8 weeks with Sertraline from 50-200 mg/d. HAMA and HAMD were used to assess the effect.Results:At the end of 8 weeks, 54 patients completed the trial. Patients of both groups had lower HAMD scores than baseline from 2 weeks, and this trend continued through the 8 weeks observation. During this period, HAMD score of the study group declined more significantly than that of the placebo group. At the end of 8 weeks, the score of HAMA of the study group was also lower than that of the placebo group. The side effects of Sertraline were mild.Conclusion:Sertraline is effective in treatment of psychiatric outpatients with dysthymia.